Report cover image

Biobanks

Publisher UnivDatos Market Insights
Published Jan 01, 2026
Length 145 Pages
SKU # Univ20880591

Description

Biobanks are structured depositories where biological specimens in the form of tissues, blood, DNA, cells, and other biological and related health and demographic information are collected, processed, stored, and handled. These samples are maintained with standardized conditions to maintain quality and usability over time, to be used in research and clinical purposes. Also, biobanks are important in enhancing biomedical research, drug development, clinical diagnostics, and personalized medicine by providing access to high-quality, well-annotated biological specimens to the researcher. They enhance research in genomics, disease mechanisms, biomarker discovery, and therapy development, leading to significant improvements in healthcare outcomes and scientific innovation.

The Biobanks market is set to show a growth rate of about 8.8% during the forecast period (2025-2033F). The global biobanks market is accelerating due to the growing demand for personalized medicine, improved diagnostic accuracy, and the development of therapeutic methods that require high-quality biological samples. Advances in sectors such as genomics, proteomics, and biotechnology have increased the need for proper organization and long-term storage of samples. Additionally, further increases in clinical research, drug discovery, and regenerative medicine investments contribute to the market growth. Moreover, the provision of government funding, favorable regulatory environments, and increased partnerships between academic institutions, pharmaceutical firms, and research organizations are enhancing biobanking infrastructures.
  • Based on the product and service category, the market is categorized into consumables, software, equipment, and services. Among these, the consumables have the largest market share since they are consumed repeatedly in large amounts, replacement cycles are short, and are needed to perform routine diagnostics, procedures, and daily operations, which guarantees the same and continuous revenue. However, the software segment is expected to grow at the fastest rate, owing to the accelerated digitalization, increased use of AI-driven analytics, cloud computing, automation, and the use of data to make decisions.
  • Based on the sample type category, the market is categorized into human tissues, cell lines, human waste products, blood products, nucleic acids, and biological fluids. Among these, blood products have the highest market share as they are used in diagnostics, disease monitoring, transfusion services, and biomedical research, along with easy availability and standardized collection methods. However, the nucleic acids segment is expected to register faster growth in the coming years, with the accelerated development in genomics, personalized medicine, molecular diagnostics, and the increased use of PCR, sequencing, and gene-targeted therapies. Additional emphasis on the use of nucleic-acid-based samples for early disease identification and precision medicine, as well as infectious disease surveillance, will further strengthen the future of this method.
  • Based on the application category, the market is segmented into therapeutics, drug discovery & clinical research, clinical diagnostics, and others. Among these, clinical diagnostics holds the largest market share because it is commonly applied to hospitals, diagnostic laboratories, and medical facilities in detecting, monitoring, and preventive screening of diseases, and consequently, the volume of tests is high and recurrent. Its hegemony is further supported by the rising number of chronic and infectious diseases in the world. However, drug discovery & clinical research will likely increase faster in the next few years due to the growth in clinical trial activity, and the recent surge in the interest of precision medicine, biologics, and advanced therapeutics, all of which increase the need for high-quality biological samples. For instance, in June 2025, BioAge Labs, Inc., which is a clinical-stage biotechnology company, announced the launch of an initiative to comprehensively profile and analyze samples from the HUNT Biobank in Norway, to enhance its drug-discovery platform.
  • For a better understanding of the demand of Biobanks, the market is analyzed based on its worldwide adoption in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and Rest of World. Among these, North America has the biggest market share with a high research infrastructure, high spending on healthcare, extensive genetic efforts, and the presence of giant biobank operators. However, the Asia-Pacific (APAC) region will experience tremendous growth because of the growing healthcare infrastructure, increasing research and development activities, a high number of patients, and growing governmental assistance towards precision medicine.
  • Some major players running in the market include Thermo Fisher Scientific Inc., Merck KGaA, Qiagen, Hamilton Company, Danaher Corporation, Becton, Dickinson, and Company (BD), Charles River Laboratories, Lonza, Stemcell Technologies, and Promocell GmbH.

Table of Contents

145 Pages
1 Market Introduction
1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation
2 Research Methodology or Assumption
2.1. Research Process of the Global Biobanks Market
2.2. Research Methodology of the Global Biobanks Market
2.3. Respondent Profile
3 Executive Summary
3.1. Industry Synopsis
3.2. Segmental Outlook
3.2.1. Market Growth Intensity
3.3. Regional Outlook
4 Market Dynamics
4.1. Drivers
4.2. Opportunity
4.3. Restraints
4.4. Trends
4.5. PESTEL Analysis
4.6. Demand Side Analysis
4.7. Supply Side Analysis
4.7.1. Merger & Acquisition
4.7.2. Collaboration & Investment Scenario
4.7.3. Industry Insights: Leading Startups and Their Unique Strategies
5 Pricing Analysis
5.1. Regional Pricing Analysis
5.2. Price Influencing Factors
6 Global Biobanks Market Revenue (USD Mn), 2023-2033F
7 Market Insights By Product And Service
7.1. Consumables
7.2. Software
7.3. Equipment
7.4. Services
8 Market Insights By Sample Type
8.1. Human Tissues
8.2. Cell Lines
8.3. Human Waste Products
8.4. Blood Products
8.5. Nucleic Acids
8.6. Biological Fluids
9 Market Insights By Application
9.1. Therapeutics
9.2. Drug Discovery & Clinical Research
9.3. Clinical Diagnostics
9.4. Others
10 Market Insights By Region
10.1. North America
10.1.1. U.S.
10.1.2. Canada
10.1.3. Rest of North America
10.2. Europe
10.2.1. Germany
10.2.2. U.K.
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Rest of Asia-Pacific
10.4. Rest of World
11 Value Chain Analysis
11.1. Marginal Analysis
11.2. List of Market Participants
12 Competitive Landscape
12.1. Competition Dashboard
12.2. Competitor Market Positioning Analysis
12.3. Porter Five Forces Analysis
13 Company Profiles
13.1. Thermo Fisher Scientific Inc.
13.1.1. Company Overview
13.1.2. Key Financials
13.1.3. SWOT Analysis
13.1.4. Product Portfolio
13.1.5. Recent Developments
13.2. Merck KGaA
13.3. Qiagen
13.4. Hamilton Company
13.5. Danaher Corporation
13.6. Becton, Dickinson, and Company (BD)
13.7. Charles River Laboratories
13.8. Lonza
13.9. Stemcell Technologies
13.10. Promocell GmbH
14 Acronyms & Assumption
15 Annexure

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us